Anthropic, PBC (ANT) Stock Analysis
Verdict: AVOID
An extremely high P/S ratio of 36x with a $41.9 billion loss makes Anthropic a highly speculative investment after its IPO.
Investment score: 30/100
Analysis as of
Is Anthropic, PBC stock worth reviewing? The TradeMates thesis
The TradeMates model rates Anthropic as AVOID after its IPO. Despite strong revenue growth to USD 4.59 billion in 2025, this is offset by a net loss of USD 41.97 billion and a P/S valuation of 36.04x.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 30/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Anthropic, PBC opportunities and risks
What speaks for ANT
- Aggressive revenue growth through Claude interfaces
What speaks against ANT
- Exorbitant Net Loss and Negative Gross Margin
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ANT | 0.0x | 36.0x | n/a | 38.3% | -342.7% | 0.0% |
| MSFT | 26.0x | 10.7x | 17.1x | 67.7% | 41.2% | 1.6% |
| ORCL | 17.0x | 4.7x | 12.0x | 64.0% | 26.4% | -8.6% |
| PANW | 574.2x | 23.8x | 278.4x | 68.9% | 3.7% | 1.5% |
| CRWD | 6916.5x | 46.2x | 561.0x | 75.2% | 1.1% | 0.6% |
| FTNT | 42.4x | 12.3x | 31.6x | 79.7% | 29.0% | 3.6% |
| Peer median | 42.4x | 12.3x | 31.6x | 68.9% | 26.4% | 1.5% |
Frequently asked questions about Anthropic, PBC (ANT)
Is ANT stock a good investment?
The TradeMates model rates Anthropic, PBC as AVOID with an investment score of 30/100. The TradeMates model rates Anthropic as AVOID after its IPO. Despite strong revenue growth to USD 4.59 billion in 2025, this is offset by a net loss of USD 41.97 billion and a P/S valuation of 36.04x. This is algorithmic model output, not personal investment advice.
Is ANT stock a buy?
The TradeMates model verdict for ANT is AVOID with an investment score of 30/100. Treat this as a model signal to review, not a personal buy recommendation.